REGiMMUNE starts Phase II study of RGI-2001 for tr..

Criou um novo artigo

2 anos

REGiMMUNE starts Phase II study of RGI-2001 for treatment of Graft-versus-host disease | #gvhd Clinical Trials Market

REGiMMUNE starts Phase II study of RGI-2001 for treatment of Graft-versus-host disease

REGiMMUNE starts Phase II study of RGI-2001 for treatment of Graft-versus-host disease

The GVHD clinical trial market research report provides an overview of the Graft Versus Host Disease (GVHD) clinical trials scenario. This report provides top-line data relating to the clinical trials on Graft Versus Host Disease (GVHD). The report includes an overview of trial numbers and

Curtir

Comentario

Compartilhar